THE CHAEUM PREMIUM NO3 face filler & Lip filler -Han's Kin Smart store
HOME ABOUT NEWS
ALL PRODUCTS BOTULINUM TOXIN DERMA FILLER BODY FILLER SKIN BOOSTER LIPOLISYS HYALURONIDASE LIDOCAINE COSMETICS

Change
country

Shopping
cart

Previous
order

Sign Up

Sign In

THE CHAEUM PREMIUM NO3 image

THE CHAEUM PREMIUM NO3

face filler & Lip filler

Manufacturer : HUGEL

Country of origin : KOREA

Chaeum is a facial filler made by ‘Hugel’, the pharmaceutical company that manufactured ‘Dermalax’. Because it is a domestic version of 'Dermalax', it is widely used in Korean plastic surgery. The 'Premium' version is a Lidocaine filler that has received CE and FDA approval.

Unit Price Chart

more than 1ea

$26.1

more than 10ea

$25.1

more than 50ea

$24.6

more than 100ea

$24.1

more than 1000ea

$23.6

$26.1

$ 26.1

Shipping is separate

Product information

of THE CHAEUM PREMIUM NO3

Basic information
Effect of procedure

Chaeum premium is designed to correct wrinkles of various depths, lip augmentation, face rejuvenation, and volumization. Chaeum Premium 3 is used to correct medium and deep wrinkles, and facial volumization.

Correct medium and deep wrinkles

Facial volumization

Applied Area

Forehead lines

Chin wrinkles

Facial volumization

Nose bridge/ridge improvement

Lip augmentation

Recommended Treatment Policy

Needle : 25G

Injection depth : Middle and deep dermis

Specifications

Type : Monophasic

Ingredients : Hyaluronic acid, Lidocaine

HA Composition : 20mg/mL

Lidocaine : 0.3%

G' Value : 300 ± 15 Pa

Packaging : 2 syringes × 1.1 ml, 4 needles per pack

Storage : 2-25℃

Features
Less pain

Constant extrusion force allows smooth and even injection, which makes the procedure easier, and less painful and also reduces the risk of injury

Minimize inflammation

Low endotoxin content (< 0.03 EU/ml) minimizes post-injection inflammation (redness, edema, painful and burning sensations)

Minimize allergic reactions

Low BDDE (< 0.5 ppm) and protein (< 0.05) loads reduce the risk of allergic reactions

Description

ADVANCED SAFETY

Inflammation and allergic reaction are minimized through the strict control of endotoxin, BDDE residue, and protein load

14~15 days of dialysis to minimize BDDE residue

Spontaneous movement of BDDE from an area of high concentration to low concentration minimizing BDDE residue

CLINICAL RESULTS

In a pivotal clinical study conducted for 48 weeks (pre-protocol group n=60), the safety and efficacy of DermalaxTM &THE CHAEUM® were compared with that of the reference device which was approved for its claim of 18 month-duration by US FDA

24 weeks

-91% of subjects showed the wrinkle improvement at 24 weeks

48 weeks

-83% of subjects showed the wrinkle improvement after 1 year

-Subjects who showed 2-level or higher improvement: DermalaxTM &THE CHAEUM® 64% vs. Reference device 54%

Related products

of THE CHAEUM PREMIUM NO3

Review & Comment

of THE CHAEUM PREMIUM NO3

Write your comment

You can be the first to leave a comment!